Proliferation of Human Corneal Endothelia in Organ Culture Stimulated by Wounding and the Engineered Human Fibroblast Growth Factor 1 Derivative TTHX1114-Reference-Cited by-同舟云学术

Proliferation of Human Corneal Endothelia in Organ Culture Stimulated by Wounding and the Engineered Human Fibroblast Growth Factor 1 Derivative TTHX1114

Published:2020-11-01 Issue:9 Volume:36 Page:686-696
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Eveleth David¹,Pizzuto Sarah¹,Weant Jessica¹,Jenkins-Eveleth Jennifer¹,Bradshaw Ralph A.¹

Affiliation:

1. Trefoil Therapeutics, Inc., San Diego, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2019.0119

Reference72 articles.

1. Fuchs Corneal Dystrophy

3. Clinical Study of Fuchs Corneal Endothelial Dystrophy Leading to Penetrating Keratoplasty

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy;Progress in Retinal and Eye Research;2024-09

2. Cell therapy in the cornea: The emerging role of microenvironment;Progress in Retinal and Eye Research;2024-09

3. Neuropeptide alpha-Melanocyte stimulating hormone preserves corneal endothelial morphology in a murine model of Fuchs dystrophy;Scientific Reports;2024-08-14

4. Safety of intraoperative autologous plasma incubation of corneal grafts for reducing endothelial cell loss: a pilot study;Frontiers in Medicine;2024-08-12

5. Emerging alternatives to keratoplasty for corneal endothelial cell dysfunction;Current Opinion in Ophthalmology;2024-06-26